rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  gplay

Rediff News  All News 

azd1222

Rediff.com  »  News  »   azd1222

  News for azd1222

  • News
  • Business

Oxford jabs effective against severe Covid: US trial

A large trial in the United States and two South American countries of the Oxford-AstraZeneca vaccine has shown 79 per cent efficacy rate at preventing symptomatic COVID-19 and 100 per cent......

Serum Institute began its journey in a small lab in stud farm

The Covishield maker's forte throughout the past half a century has been a combination of affordable vaccines and high volumes. Its tetanus, diphtheria and measles vaccines are known throughout the......

Oxford/AstraZeneca COVID-19 vaccine approved by UK regulator

The coronavirus vaccine designed by scientists at the University of Oxford and produced by AstraZeneca was on Wednesday approved for human use by the United Kingdom’s independent regulator.......

Oxford vaccine set to get UK clearance by year-end

The Oxford University vaccine against COVID-19 being produced by AstraZeneca is likely to get regulatory approval from the United Kingdom’s independent regulator by the end of this year for a......

Oxford COVID-19 vaccine 70% effective, results show

Pharma major AstraZeneca said on Monday that an interim analysis of clinical trials of its COVID-19 vaccine in the United Kingdom and Brazil showed that it was 70 per cent effective on average,......

Serum Institute to start phase-2 trials of Oxford-AstraZeneca vaccine

The institute expects to complete both, phase-2 and 3 trials in India by the end of this year. Pune's Serum Institute of India (SII) is all set to start phase-2 clinical trials of the Oxford......

Serum Institute to provide Covid vaccine at Rs 250 a dose

Serum Institute of India plans to make 300 million doses of AZD1222 by December, and will begin phase-2 trials soon. It has also tied up with Novavax for development and commercialisation of its......

Meet Adar Poonawala, India's COVID-19 vaccine man

Serum Institute is investing $200 million to create capacities for the COVID-19 vaccine.Sohini Das profiles its 39-year-old CEO. IMAGE: Adar Poonawalla, right, and his father Dr Cyrus S......

'We will price Covid vaccine below Rs 1,000'

'Once the trials are successful in India and the UK, we are certain that COVISHIELD will be one of the first vaccines to be introduced.' IMAGE: The Reference Center for Special Immunobiologicals......
  Web results for azd1222
US trial

A large trial in the United States and two South American countries of the Oxford-AstraZeneca vaccine has shown 79 per cent efficacy rate at... ...

http://www.rediff.com/news/report/oxford-jabs-effective-against-severe-covid-us-trial/20210322.htm

Related Tags


  1. gujarat
  2. bjp
  3. india
  4. lok sabha
  5. supreme court
  6. upa
  7. bharatiya janata party
  8. congress
  9. new delhi
  10. united progressive alliance
  11. ahmedabad
  12. sonia gandhi
  13. nda
  14. rahul gandhi
  15. rajnath singh
  16. nitin gadkari
  17. delhi
  18. manmohan singh
  19. bihar
  20. national democratic alliance
  21. jd-u
  22. nitish kumar
  23. rashtriya swayamsevak sangh
  24. uttar pradesh
  25. photo
  26. advani
  27. central bureau of investigation
  28. rss
  29. janata dal-united
  30. ips

Top Coverage News


Coming to India and making

Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z